glp 1 receptor agonist contraindications What are the for tirzepatide (glucagon-like peptide-1 (GLP -1) and glucose-dependent insulinotropic polypeptide (GIP) agonist) in patients with various medical histories and demographics? Benefits and Risks of GLP-1

I was on a GLP medication for 3 years, but I had to stop due to recurrent pancreatitis. Anonymous Some explained why GLP-1 medications werent considered an option by their doctors

This is great for people trying to lose weight, but eating in deficit without controlling for a few different variables can produce adverse health effects as well

We need to see how patients fare over several years, not just several months, to truly understand the risk-benefit profile before we can determine its ultimate place in treatment. Having medications like eloralintide, which work through a different mechanism, may provide a vital alternative and increase our ability to personalize treatment for the individual

Telogen effluvium usually appears two to three months after the triggering event

Recent concerns about pancreatitis and gallbladder disease warrant baseline assessment